It’s hard to be all that negative when there are so many leaders from so many groups right in front of us.
For example: Don’t you marvel at Procter & Gamble rising again in the face of higher commodity prices? Unless it’s just oil. Clorox is rallying too, as well as Mead Johnson, Coca-Cola, UnitedHealth, and Perrigo.
Then there is Gilead with its climb, as it dawns on people that we have a potential winner in the Hepatitis C war. Allergan’s got some spring and, you know, I think that it has become a chronically undervalued story because of what I bet will be a one-time slowdown in its core opthamalogic business.
— Option Monster